This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 1452
From Proteopedia
| Line 1: | Line 1: | ||
| - | {{Sandbox_Reserved_Telford2018}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | + | <scene name='77/778332/1vax/1'>Text To Be Displayed</scene>{{Sandbox_Reserved_Telford2018}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> |
==Uricase== | ==Uricase== | ||
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | ||
| Line 24: | Line 24: | ||
== Structural highlights == | == Structural highlights == | ||
| - | Uricase is mainly located in the liver where it forms an elctron dense crystalline core in peroxisomes. It is a tetramer of identical subunits each containing copper binding sites. X-ray crystallography shows that uric acid binds to the active site as a monoanion and is deprotonated as a dianion which is then stabilized by Arg 176 and Gln 228. Uricase can be inhibited by both cyanide and chloride ions. Oxonate competitively inhibits uricase. | + | Uricase is mainly located in the liver where it forms an elctron dense crystalline core in peroxisomes. It is a tetramer of identical subunits each containing copper binding sites. X-ray crystallography shows that uric acid binds to the active site as a monoanion and is deprotonated as a dianion which is then stabilized by <scene name='77/778332/1vax/1'>Arg 176</scene> and Gln 228. Uricase can be inhibited by both cyanide and chloride ions. Oxonate competitively inhibits uricase. |
This is <scene name='77/778332/1vax/1'>uricase</scene> without a ligand. | This is <scene name='77/778332/1vax/1'>uricase</scene> without a ligand. | ||
You can view uricase with a ligand <scene name='77/778332/4mb8/1'>here.</scene> | You can view uricase with a ligand <scene name='77/778332/4mb8/1'>here.</scene> | ||
Revision as of 19:35, 2 May 2018
| This Sandbox is Reserved from Jan 22 through May 22, 2018 for use in the course Biochemistry II taught by Jason Telford at the Maryville University, St. Louis, Missouri, USA. This reservation includes Sandbox Reserved 1446 through Sandbox Reserved 1455. |
To get started:
More help: Help:Editing |
Uricase
| |||||||||||
References
Bonifacio, and Vicente. “Uric Acid and Evolution | Rheumatology | Oxford Academic.” OUP Academic, Oxford University Press, 13 July 2010, academic.oup.com/rheumatology/article/49/11/2010/1785765.
Kratzer, James T., et al. “Evolutionary History and Metabolic Insights of Ancient Mammalian Uricases.” PNAS, National Academy of Sciences, 11 Mar. 2014, www.pnas.org/content/111/10/3763.short.
Ortlund, E.o., and M.n. Murphy. “Evolutionary History and Metabolic Insights of Ancient Mammalian Uricases.” Evolutionary History and Metabolic Insights of Ancient Mammalian Uricases, 2014, doi:10.2210/pdb4mb8/pdb.
